These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 29716649)

  • 1. Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.
    Li F; Zhou Z; Wu A; Cai Y; Wu H; Chen M; Liang S
    Radiat Oncol; 2018 May; 13(1):82. PubMed ID: 29716649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities.
    Kobayashi H; Wakuda K; Naito T; Mamesaya N; Omori S; Ono A; Kenmotsu H; Murakami H; Endo M; Harada H; Gon Y; Takahashi T
    Radiat Oncol; 2021 Mar; 16(1):52. PubMed ID: 33731123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
    Ren C; Ji T; Liu T; Dang J; Li G
    Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients.
    Meng Y; Yang H; Wang W; Tang X; Jiang C; Shen Y; Luo W
    Radiat Oncol; 2019 Jan; 14(1):7. PubMed ID: 30642354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease.
    Bahig H; Filion E; Vu T; Chalaoui J; Lambert L; Roberge D; Gagnon M; Fortin B; Béliveau-Nadeau D; Mathieu D; Campeau MP
    Pract Radiat Oncol; 2016; 6(5):367-374. PubMed ID: 27068780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer.
    Ozawa Y; Abe T; Omae M; Matsui T; Kato M; Hasegawa H; Enomoto Y; Ishihara T; Inui N; Yamada K; Yokomura K; Suda T
    PLoS One; 2015; 10(10):e0140437. PubMed ID: 26460792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
    Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
    Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy.
    Li F; Liu H; Wu H; Liang S; Xu Y
    Radiat Oncol; 2021 Apr; 16(1):70. PubMed ID: 33849579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
    Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
    Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of radiation pneumopathy and generalised radiological changes after radiotherapy are independent negative prognostic factors for survival in non-small cell lung cancer patients.
    Farr KP; Khalil AA; Knap MM; Møller DS; Grau C
    Radiother Oncol; 2013 Jun; 107(3):382-8. PubMed ID: 23726117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes.
    Ito M; Katano T; Okada H; Sakuragi A; Minami Y; Abe S; Adachi S; Oshima Y; Ohashi W; Kubo A; Fukui T; Ito S; Suzuki K
    Radiol Oncol; 2023 Jun; 57(2):229-238. PubMed ID: 37078697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer.
    Kimura T; Doi Y; Nakashima T; Imano N; Kawabata H; Nishibuchi I; Okabe T; Kenjo M; Ozawa S; Murakami Y; Nagata Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):778-87. PubMed ID: 26530746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis.
    Szejniuk WM; Nielsen MS; Takács-Szabó Z; Pawlowski J; Al-Saadi SS; Maidas P; Bøgsted M; McCulloch T; Frøkjær JB; Falkmer UG; Røe OD
    Radiat Oncol; 2021 Jul; 16(1):131. PubMed ID: 34266462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
    Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy.
    Wijsman R; Dankers FJWM; Troost EGC; Hoffmann AL; van der Heijden EHFM; de Geus-Oei LF; Bussink J
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):434-441. PubMed ID: 28871994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis.
    Lee YH; Kim YS; Lee SN; Lee HC; Oh SJ; Kim SJ; Kim YK; Han DH; Yoo IeR; Kang JH; Hong SH
    Cancer Res Treat; 2015 Oct; 47(4):676-86. PubMed ID: 25687856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
    Lee YH; Choi HS; Jeong H; Kang KM; Song JH; Lee WS; Lee GW; Song HN; Kim HG; Kang MH; Rhee DY; Jeong BK
    Clin Respir J; 2018 Mar; 12(3):1264-1273. PubMed ID: 28618180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suggestion for a new grading scale for radiation induced pneumonitis based on radiological findings of computerized tomography: correlation with clinical and radiotherapeutic parameters in lung cancer patients.
    Kouloulias V; Zygogianni A; Efstathopoulos E; Victoria O; Christos A; Pantelis K; Koutoulidis V; Kouvaris J; Sandilos P; Varela M; Aytas I; Gouliamos A; Kelekis N
    Asian Pac J Cancer Prev; 2013; 14(5):2717-22. PubMed ID: 23803021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy.
    Ryckman JM; Baine M; Carmicheal J; Osayande F; Sleightholm R; Samson K; Zheng D; Zhen W; Lin C; Zhang C
    Radiat Oncol; 2020 Feb; 15(1):33. PubMed ID: 32054487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.